Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Buy
1,944
+513
+36% +$162K 0.07% 425
2026
Q1
$470K Sell
1,431
-5,675
-80% -$2.04M 0.06% 432
2025
Q4
$2.5M Buy
7,106
+6,451
+985% +$2.35M 0.56% 12
2025
Q3
$242K Sell
655
-777
-54% -$300K 0.09% 386
2025
Q2
$567K Buy
+1,432
New +$536K 0.18% 189
2024
Q4
Sell
-2,670
Closed -$965K 617
2024
Q3
$965K Buy
+2,670
New +$922K 0.29% 132
2024
Q2
Sell
-700
Closed -$251K 722
2024
Q1
$251K Buy
+700
New +$236K 0.06% 466

Other funds holding SYK

AXQ Capital's SYK Position: Q2 2026 in Review

AXQ Capital increased its Stryker (SYK) stake by 36% in Q2 2026, buying an estimated $162K and bringing the position to 1,944 shares worth $612K. The position accounts for 0.07% of the portfolio, ranked #425.

AXQ Capital first reported a position in SYK in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.5M in Q4 2025. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • AXQ Capital held 1,944 shares of Stryker worth $612K as of Q2 2026.
  • AXQ Capital bought 513 Stryker shares in Q2 2026, an estimated $162K.
  • Stryker made up 0.07% of AXQ Capital's portfolio in Q2 2026, its #425 holding.
  • AXQ Capital first reported a position in Stryker in Q1 2024 and has held it in 7 quarters since.
  • AXQ Capital's Stryker position peaked at $2.5M in Q4 2025.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.